Between 2009 and 2021, Novo Nordisk A-S (NVO) returned 1,314.8% and the Nasdaq Composite (IXIC) returned 890.9%.
| DATE | the Nasdaq Composite | Novo Nordisk A-S |
|---|---|---|
December 2021 | $15,644.97 | $52.43 |
November 2021 | $15,537.69 | $50.01 |
October 2021 | $15,498.39 | $51.56 |
September 2021 | $14,448.58 | $44.95 |
August 2021 | $15,259.24 | $46.80 |
July 2021 | $14,672.68 | $43.12 |
June 2021 | $14,503.95 | $39.00 |
May 2021 | $13,748.74 | $36.74 |
April 2021 | $13,962.68 | $34.43 |
March 2021 | $13,246.87 | $31.39 |
February 2021 | $13,192.35 | $32.71 |
January 2021 | $13,070.69 | $31.95 |
December 2020 | $12,888.28 | $32.07 |
November 2020 | $12,198.74 | $30.82 |
October 2020 | $10,911.59 | $29.33 |
September 2020 | $11,167.51 | $31.87 |
August 2020 | $11,775.46 | $30.32 |
July 2020 | $10,745.27 | $29.76 |
June 2020 | $10,058.77 | $29.83 |
May 2020 | $9,489.87 | $30.04 |
April 2020 | $8,889.55 | $28.85 |
March 2020 | $7,700.10 | $27.42 |
February 2020 | $8,567.37 | $26.11 |
January 2020 | $9,150.94 | $27.32 |
December 2019 | $8,972.60 | $26.00 |
